aficamten
cytokinetics
['hypertrophic cardiomyopathy', 'obstructive hypertrophic cardiomyopathy ', 'cardiomyopathy', 'cardio']
aficamten reduces resting and provoked lvot gradients in obstructive hypertrophic cardiomyopathy patients, and most experienced symptom improvement by week 48. per data from dr. sara saberi from at acc.23. #acc23 
Heart failure/transplant cardiologist @UHhospitals @CWRUSOM by day; baseball fan always. Tweets reflect my own personal opinion.